"Adenosine Triphosphate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter.
| Descriptor ID |
D000255
|
| MeSH Number(s) |
D03.633.100.759.646.138.236 D13.695.667.138.236 D13.695.827.068.236
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Adenosine Triphosphate".
Below are MeSH descriptors whose meaning is more specific than "Adenosine Triphosphate".
This graph shows the total number of publications written about "Adenosine Triphosphate" by people in this website by year, and whether "Adenosine Triphosphate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 3 | 3 |
| 1997 | 1 | 1 | 2 |
| 1998 | 2 | 3 | 5 |
| 1999 | 4 | 3 | 7 |
| 2000 | 1 | 2 | 3 |
| 2001 | 1 | 5 | 6 |
| 2002 | 2 | 2 | 4 |
| 2003 | 0 | 6 | 6 |
| 2004 | 4 | 8 | 12 |
| 2005 | 1 | 2 | 3 |
| 2006 | 3 | 5 | 8 |
| 2007 | 2 | 7 | 9 |
| 2008 | 0 | 3 | 3 |
| 2009 | 2 | 3 | 5 |
| 2010 | 2 | 6 | 8 |
| 2011 | 1 | 3 | 4 |
| 2012 | 1 | 5 | 6 |
| 2013 | 5 | 10 | 15 |
| 2014 | 1 | 3 | 4 |
| 2015 | 1 | 5 | 6 |
| 2016 | 4 | 7 | 11 |
| 2017 | 1 | 7 | 8 |
| 2018 | 1 | 2 | 3 |
| 2019 | 1 | 1 | 2 |
| 2020 | 0 | 7 | 7 |
| 2021 | 0 | 2 | 2 |
| 2022 | 1 | 7 | 8 |
| 2023 | 1 | 1 | 2 |
| 2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adenosine Triphosphate" by people in Profiles.
-
Intracellular ATP concentration is a key regulator of bacterial cell fate. J Bacteriol. 2024 12 19; 206(12):e0020824.
-
Oligodendroglial fatty acid metabolism as a central nervous system energy reserve. Nat Neurosci. 2024 Oct; 27(10):1934-1944.
-
Functional and Structural Characterization of Clinical-Stage Janus Kinase 2 Inhibitors Identifies Determinants for Drug Selectivity. J Med Chem. 2024 Jun 27; 67(12):10012-10024.
-
The SWI/SNF ATP-dependent chromatin remodeling complex in cell lineage priming and early development. Biochem Soc Trans. 2024 04 24; 52(2):603-616.
-
Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies. Cancer Res Commun. 2024 02 12; 4(2):378-387.
-
Distribution of P2Y and P2X purinergic receptor expression within the intestine. Am J Physiol Gastrointest Liver Physiol. 2024 02 01; 326(2):G107-G119.
-
The AT-hook is an evolutionarily conserved auto-regulatory domain of SWI/SNF required for cell lineage priming. Nat Commun. 2023 08 04; 14(1):4682.
-
RAD51C-XRCC3 structure and cancer patient mutations define DNA replication roles. Nat Commun. 2023 07 24; 14(1):4445.
-
Exome sequence analysis of rare frequency variants in Late-Onset Alzheimer Disease. Metab Brain Dis. 2023 08; 38(6):2025-2036.
-
An integrated investigation of structural and pathway alteration caused by PIK3CA and TP53 mutations identified in cfDNA of metastatic breast cancer. J Cell Biochem. 2023 02; 124(2):188-204.